another option

Teva Will Try Again To Get FDA Approval On Epipen Competitor, By 2018

Teva Will Try Again To Get FDA Approval On Epipen Competitor, By 2018

The price of the EpiPen emergency allergy medication soared by 400% to 600% over the last decade, in part due to a lack of competition. In February, the FDA rejected a potential competing injector from Teva Pharmaceuticals, but now the company says it still hopes to get an EpiPen alternative in pharmacies — at some point in the next two years.  [More]

Mike Mozart

Walmart Partners With Uber, Lyft For Online Grocery Delivery

Shoppers in more than a dozen cities can already order groceries from Walmart.com then later have someone bring their order out to their waiting car. Soon, these folks won’t even have to leave home. [More]